Literature DB >> 7285016

Utilization of 5-fluoro-2'-deoxyuridine triphosphate and 5-fluoro-2'-deoxycytidine triphosphate in DNA synthesis by DNA polymerases alpha and beta from calf thymus.

M Tanaka, S Yoshida, M Saneyoshi, T Yamaguchi.   

Abstract

Chemically synthesized 5-fluoro-2'-deoxyuridine 5'-triphosphate and 5-fluoro-2'-deoxycytidine 5'-triphosphate were used efficiently as substitutes for DNA synthesis catalyzed by DNA polymerases alpha or beta from calf thymus. 5-fluoro-2'-deoxyuridine 5'-triphosphate and 5'-fluoro-2'-deoxycytidine 5'-triphosphate were incorporated into DNA in place of deoxythymidine 5'-triphosphate and deoxycytidine 5'-triphosphate, respectively. The incorporated pyrimidine analogs supported further elongation of DNA. The apparent Km's for 5-fluorodeoxyuridine 5'-triphosphate in the reaction of DNA polymerases alpha and beta were 4.3 and 15.4 microM, while those of 5-fluorodeoxycytidine 5'-triphosphate with DNA polymerases alpha and beta were 7.7 and 8.8 microM, respectively, which are comparable to Km's for natural substrates. These results suggest the new possibility that the fluorinated pyrimidines are incorporated into DNA via their triphosphate forms to exhibit their cytostatic actions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285016

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Dynamics of uracil and 5-fluorouracil in DNA.

Authors:  Jared B Parker; James T Stivers
Journal:  Biochemistry       Date:  2011-01-13       Impact factor: 3.162

2.  Binding of the EcoRII methyltransferase to 5-fluorocytosine-containing DNA. Isolation of a bound peptide.

Authors:  S Friedman; N Ansari
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

3.  DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells.

Authors:  J D Schuetz; H J Wallace; R B Diasio
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Structures of a DNA Polymerase Inserting Therapeutic Nucleotide Analogues.

Authors:  Matthew A Schaich; Mallory R Smith; Ashley S Cloud; Sean M Holloran; Bret D Freudenthal
Journal:  Chem Res Toxicol       Date:  2017-09-01       Impact factor: 3.739

5.  Isolation of a Saccharomyces cerevisiae mutant strain deficient in deoxycytidylate deaminase activity and partial characterization of the enzyme.

Authors:  E M McIntosh; R H Haynes
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

Review 6.  Participation of DNA repair in the response to 5-fluorouracil.

Authors:  M D Wyatt; D M Wilson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

7.  Increased stability of nucleic acids containing 7-deaza-guanosine and 7-deaza-adenosine may enable rapid DNA sequencing by matrix-assisted laser desorption mass spectrometry.

Authors:  K Schneider; B T Chait
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

Review 8.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

9.  Capecitabine in the management of colorectal cancer.

Authors:  Bradford R Hirsch; S Yousuf Zafar
Journal:  Cancer Manag Res       Date:  2011-03-24       Impact factor: 3.989

10.  Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs.

Authors:  Jérémy Béguin; Matthias Kohlhauer; Eve Laloy; Frédérique Degorce; Baptiste Moreau; Éric Quéméneur; Philippe Erbs; Bernard Klonjkowski; Christelle Maurey
Journal:  BMC Vet Res       Date:  2021-06-21       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.